SCHEMBL4635245

SCHEMBL4635245

[C-]#[N+]c1nc(N2CCCC(NC(=O)OC(C)(C)C)C2)n(CC=C(C)C)c1OC(=O)OCC

nearest known ligand 0.41

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
BTK Q06187 3/20 0.41
JAK3 P52333 2/20 0.41
DPP4 P27487 12/20 0.40
MAP4K4 O95819 2/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
EGFR P00533 1/20 0.36
LCK P06239 1/20 0.36
PDE10A Q9Y233 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4635283 0.89 MAP4K4 (0.44) BTKJAK3DPP4MAP4K4CA1
SCHEMBL4635505 0.88 BTK (0.41) BTKJAK3DPP4MAP4K4CA1
SCHEMBL3967464 0.88 DPP4 (0.42) BTKJAK3DPP4MAP4K4CA1
SCHEMBL4636249 0.87 JAK3 (0.42) BTKJAK3DPP4MAP4K4CA1
SCHEMBL6843485 0.84 CA1 (0.43) BTKJAK3DPP4MAP4K4CA1
SCHEMBL3971382 0.80 BTK (0.41) BTKJAK3DPP4MAP4K4CA1
SCHEMBL5437210 0.79 MAP4K4 (0.46) BTKJAK3DPP4MAP4K4CA1
SCHEMBL556164 0.79 MAP4K4 (0.46) BTKJAK3DPP4MAP4K4CA1
SCHEMBL5435581 0.79 BTK (0.42) BTKJAK3DPP4MAP4K4CA1
SCHEMBL556256 0.78 BTK (0.41) BTKJAK3DPP4MAP4K4CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532150-B1 NOVEL PURINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2008-06-11 EP disclosed
EP-1532150-A1 NOVEL PURINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-05-25 EP disclosed
WO-2004018469-A1 NOVEL PURINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-03-04 WO disclosed